News
Blogs
From Trials to Results: How Weight Loss Studies Are Changing Lives
Weight loss studies are revolutionizing the way individuals approach sustainable weight management and overall health improvement. These clinical trials are not only uncovering the science ...
Read More 
How Vaccines Go From Lab to Clinic: The Journey Through Clinical Trials
Vaccines have been pivotal in improving global health, eradicating diseases like smallpox, and significantly reducing the prevalence of others such as polio and measles. But ...
Read More 
Why Participate in Vaccine Clinical Trials? The Benefits of Contributing to Life-Saving Research
Understanding the Importance of Vaccine Clinical Trials Vaccine clinical trials play a critical role in advancing public health and protecting communities from diseases. By participating ...
Read More 
Financial Incentives for Participating in Vaccine Clinical Trials: How You Can Benefit
Participating in vaccine clinical trials offers a unique opportunity to contribute to medical advancements while also receiving financial compensation. Many individuals are surprised to learn ...
Read More 
Breaking Barriers: How Vaccine Clinical Trials Are Improving Healthcare in Rural Communities
The Role of Vaccine Clinical Trials in Advancing Rural Healthcare Vaccine clinical trials are playing a transformative role in improving healthcare access and outcomes in ...
Read More 
Do You Get Paid for Clinical Trials? Understanding Compensation and Benefits for Participants
Clinical trials are crucial in advancing medical science, developing new treatments, and improving patient care. However, many potential participants often wonder, "Do you get paid ...
Read More In The Community
al.com
Monoclonal antibodies ‘the answer’ to Alabama’s COVID surge, doctors say
We witnessed first hand the effectiveness of the Monoclonal Antibody Therapy in subduing the COVID-19 virus. Simply put, these are antibodies made in a lab to help stimulate your body’s defense to the Virus. Very safe and effective treatment.
sabbiotherapeutics.com
SAB Biotherapeutics Announces First Patient Dosed in Phase 3 NIH ACTIV-2 Trial Evaluating SAB-185 for Treatment of COVID-19
Being part of cutting-edge and relevant research is not always an easy path but a quite meaningful one. Our heartfelt gratitude goes out to our patients and staff for their participation and hard work!
